Literature DB >> 2504412

Hypersensitivity vasculitis due to ofloxacin.

D Huminer1, J D Cohen, R Majadla, S Dux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2504412      PMCID： PMC1837182          DOI： 10.1136/bmj.299.6694.303

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Unusual autoimmune manifestations in furosemide-associated hypersensitivity angiitis.

Authors:  R Y Lin
Journal:  N Y State J Med       Date:  1988-08

2.  Ciprofloxacin-induced vasculitis.

Authors:  U Choe; B M Rothschild; L Laitman
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

3.  Side effects of ofloxacin in clinical trials and in postmarketing surveillance.

Authors:  G Jüngst; R Mohr
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 4.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546
  4 in total
  10 in total

1.  Orbital inflammatory pseudotumor due to hypersensitivity vasculitis and mononeuritis multiplex in a patient with atypical, cANCA-positive Wegener's granulomatosis.

Authors:  Jörg Kaufmann; Eberhard Schulze; Ulrich Voigt; Jürgen Strobel; Gert Hein; Günter Stein
Journal:  Rheumatol Int       Date:  2003-04-17       Impact factor: 2.631

Review 2.  Tolerability of fluoroquinolone antibiotics. Past, present and future.

Authors:  P Ball; G Tillotson
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

3.  Cutaneous vasculitis associated with fluoroquinolones.

Authors:  G Maunz; T Conzett; W Zimmerli
Journal:  Infection       Date:  2009-08-07       Impact factor: 3.553

Review 4.  [Comparison of the adverse effect profile of different substances such as penicillins, tetracyclines, sulfonamides and quinolones].

Authors:  H Keller
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 5.  Clinical features and management of adverse effects of quinolone antibacterials.

Authors:  J H Paton; D S Reeves
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

Review 6.  Ceftriaxone-induced leukocytoclastic vasculitis: a case report and literature review of antibiotic-induced leukocytoclastic vasculitis.

Authors:  Aseel A Almasoudi; Eman S Bablghaith; Samaher I Alaauldeen; Ayman M Falemban; Ahlam A Sherbeeni; Adeeb A Bulkhi
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

Review 7.  Drug-induced severe skin reactions. Incidence, management and prevention.

Authors:  P Wolkenstein; J Revuz
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

8.  Post-marketing surveillance of quinolones 1988-1990.

Authors:  P G Davey; T McDonald; G Lindsay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 9.  Allergic emergencies encountered by the dermatologist. Severe cutaneous adverse drug reactions.

Authors:  P Wolkenstein; J Revuz
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 10.817

10.  Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy.

Authors:  Dana M Blyth; Elizabeth Markelz; Jason F Okulicz
Journal:  Infect Dis Rep       Date:  2012-01-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.